Impact of Weight on Clinical Outcomes of Edoxaban Therapy in Atrial Fibrillation Patients Included in the ETNA-AF-Europe Registry

Background: Extremes of body weight may alter exposure to non-vitamin K antagonist oral anticoagulants and thereby impact clinical outcomes. This ETNA-AF-Europe sub-analysis assessed 1-year outcomes in routine care patients with atrial fibrillation across a range of body weight groups treated with e...

Descripción completa

Detalles Bibliográficos
Autores principales: Boriani, Giuseppe, De Caterina, Raffaele, Manu, Marius Constantin, Souza, José, Pecen, Ladislav, Kirchhof, Paulus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269173/
https://www.ncbi.nlm.nih.gov/pubmed/34209595
http://dx.doi.org/10.3390/jcm10132879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269173/
https://www.ncbi.nlm.nih.gov/pubmed/34209595
http://dx.doi.org/10.3390/jcm10132879

Ejemplares similares